TargetMol

Boldine

Product Code:
 
TAR-T5720
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T5720-10mg10mg£103.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5720-25mg25mg£130.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5720-50mg50mg£170.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5720-100mg100mg£229.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5720-200mg200mg£309.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Boldine is a natual product .Boldine displays anti-cancer, cytoprotective , anti-oxidant and anti-inflammatory activities.
CAS:
476-70-0
Formula:
C19H21NO4
Molecular Weight:
327.38
Pathway:
NF-κb
Purity:
0.98
SMILES:
[H][C@@]12Cc3cc(O)c(OC)cc3-c3c(OC)c(O)cc(CCN1C)c23
Target:
RANKL/RANK

References

Gerhardt, Dani?li, Bertola G , Dietrich, Fabr?cia, et al. Boldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3?[J]. Urologic Oncology: Seminars and Original Investigations, 2014, 32(1):36.e1-36.e9. Lau Y S , Tian X Y , Mustafa M R , et al. Boldine improves endothelial function in diabetic ,?db/db , mice through inhibition of angiotensin II-mediated BMP4-oxidative stress cascade[J]. British Journal of Pharmacology, 2013, 170(6):1190-1198.